πŸ‡ΊπŸ‡Έ FDA
Patent

US 7947649

Liquid buffered GDF-5 formulations

granted A61KA61K38/1875A61K47/12

Quick answer

US patent 7947649 (Liquid buffered GDF-5 formulations) held by Advanced Technologies and Regenerative Medicine, LLC expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Advanced Technologies and Regenerative Medicine, LLC
Grant date
Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/1875, A61K47/12, A61K9/0019, A61P